DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
T84.66
1
Antibody
Investigational
Unknown
Unknown
Unknown
Carcinoembryonic antigen-related cell adhesion molecule 5 binding agent
T84.66
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TUROFEXORATE ISOPROPYL
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Bile acid receptor FXR agonist
TUROFEXORATE ISOPROPYL
×
Maximum Phase:
1
First Approval:
None
UNII:
S6KDM312I5
Molecule Type:
Small molecule
Molecular Formula:
C25H24F2N2O3
Molecular Weight:
438.47
AlogP:
5.17
PSA:
62.4
HBD:
1.0
HBA:
#RotB:
3.0
Source:
MCAF5352A
1
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
MCAF5352A
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ELTANEXOR
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Myeloid; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Neoplasms
Unknown
ELTANEXOR
×
Maximum Phase:
1
First Approval:
None
UNII:
Q59IQJ9NTK
Molecule Type:
Small molecule
Molecular Formula:
C17H10F6N6O
Molecular Weight:
428.3
AlogP:
3.26
PSA:
99.58
HBD:
1.0
HBA:
#RotB:
4.0
Source:
AZD-7648
1
Unknown
Investigational
Unknown
Unknown
Neoplasms
Unknown
AZD-7648
×
Maximum Phase:
1
First Approval:
None
UNII:
97A09L5JCK
Molecule Type:
Unknown
Molecular Formula:
C18H20N8O2
Molecular Weight:
380.41
AlogP:
1.58
PSA:
104.16
HBD:
1.0
HBA:
#RotB:
3.0
Source:
INDIUM IN 111 ALTUMOMAB PENTETATE
1
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
INDIUM IN 111 ALTUMOMAB PENTETATE
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
NP-015
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
NP-015
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
NT-219
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
NT-219
×
Maximum Phase:
1
First Approval:
None
UNII:
K1WT1A1UP5
Molecule Type:
Small molecule
Molecular Formula:
C16H14BrNO5S
Molecular Weight:
412.26
AlogP:
3.11
PSA:
113.18
HBD:
6.0
HBA:
#RotB:
4.0
Source:
SIBOFIMLOC
1
Small molecule
Investigational
Unknown
Unknown
Crohn Disease
Unknown
SIBOFIMLOC
×
Maximum Phase:
1
First Approval:
None
UNII:
00OF00QZC4
Molecule Type:
Small molecule
Molecular Formula:
C35H39NO11
Molecular Weight:
649.69
AlogP:
-2.02
PSA:
200.61
HBD:
8.0
HBA:
#RotB:
2.0
Source:
OSALMID
1
Small molecule
Investigational
Unknown
Unknown
Multiple Myeloma
Unknown
OSALMID
×
Maximum Phase:
1
First Approval:
None
UNII:
89741L759Z
Molecule Type:
Small molecule
Molecular Formula:
C13H11NO3
Molecular Weight:
229.24
AlogP:
2.35
PSA:
69.56
HBD:
3.0
HBA:
#RotB:
2.0
Source:
MDX-1342
1
Antibody
Investigational
Unknown
Unknown
Arthritis, Rheumatoid; Leukemia, Lymphocytic, Chronic, B-Cell
B-lymphocyte antigen CD19 binding agent
MDX-1342
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SOBI-003
1
Unknown
Investigational
Unknown
Unknown
Mucopolysaccharidosis III
Unknown
SOBI-003
×
Maximum Phase:
1
First Approval:
None
UNII:
ZS87P77DQC
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SECLIDEMSTAT
1
Small molecule
Investigational
Unknown
Unknown
Desmoplastic Small Round Cell Tumor; Fibroma; Fibrosarcoma; Histiocytoma; Liposarcoma, Myxoid; Myoepithelioma; Neoplasms; Sarcoma; Sarcoma, Clear Cell; Sarcoma, Ewing
Unknown
SECLIDEMSTAT
×
Maximum Phase:
1
First Approval:
None
UNII:
TYH386V3WJ
Molecule Type:
Small molecule
Molecular Formula:
C20H23ClN4O4S
Molecular Weight:
450.95
AlogP:
2.14
PSA:
102.31
HBD:
2.0
HBA:
#RotB:
5.0
Source:
UNESBULIN
1
Small molecule
Investigational
Unknown
Unknown
Diffuse Intrinsic Pontine Glioma; Neoplasms; Leiomyosarcoma
Unknown
UNESBULIN
×
Maximum Phase:
1
First Approval:
None
UNII:
Z4HZ70S62Q
Molecule Type:
Small molecule
Molecular Formula:
C19H13F5N6
Molecular Weight:
420.35
AlogP:
4.75
PSA:
81.65
HBD:
2.0
HBA:
#RotB:
3.0
Source:
SAR441236
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
SAR441236
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
REGN-5678
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
REGN-5678
×
Maximum Phase:
1
First Approval:
None
UNII:
M355PGI1TG
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CYTOCHLOR
1
Small molecule
Investigational
Unknown
Unknown
Central Nervous System Neoplasms; Head and Neck Neoplasms
Unknown
CYTOCHLOR
×
Maximum Phase:
1
First Approval:
None
UNII:
J14D49ZN55
Molecule Type:
Small molecule
Molecular Formula:
C9H12ClN3O4
Molecular Weight:
261.67
AlogP:
-0.88
PSA:
110.6
HBD:
3.0
HBA:
#RotB:
2.0
Source:
HYDROXYNORKETAMINE, (2R,6R)
1
Small molecule
Investigational
Unknown
Unknown
Neuralgia
Unknown
HYDROXYNORKETAMINE, (2R,6R)
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C12H14ClNO2
Molecular Weight:
239.7
AlogP:
1.61
PSA:
63.32
HBD:
2.0
HBA:
#RotB:
1.0
Source:
GNKG168
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
GNKG168
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BALAFILCON A
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BALAFILCON A
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BIO89-100
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
BIO89-100
×
Maximum Phase:
1
First Approval:
None
UNII:
UO870O6MFS
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PEGTIBATINASE
1
Enzyme
Investigational
Unknown
Unknown
Homocystinuria
Unknown
PEGTIBATINASE
×
Maximum Phase:
1
First Approval:
None
UNII:
3G3529LUQ7
Molecule Type:
Enzyme
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ZIRCONIUM ZR-89-DESFERRIOXAMINE-IAB22M2C
1
Unknown
Investigational
Unknown
Unknown
Lymphoma, Non-Hodgkin
Unknown
ZIRCONIUM ZR-89-DESFERRIOXAMINE-IAB22M2C
×
Maximum Phase:
1
First Approval:
None
UNII:
J6AJI0OZ1O
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MEDI-547
1
Unknown
Investigational
Unknown
Unknown
Neoplasms
Unknown
MEDI-547
×
Maximum Phase:
1
First Approval:
None
UNII:
D21E6RU881
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SELITRECTINIB
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Neurotrophic tyrosine kinase receptor inhibitor
SELITRECTINIB
×
Maximum Phase:
1
First Approval:
None
UNII:
0J45910S3X
Molecule Type:
Small molecule
Molecular Formula:
C20H21FN6O
Molecular Weight:
380.43
AlogP:
2.67
PSA:
75.42
HBD:
1.0
HBA:
#RotB:
0.0
Source:
REBAUDIOSIDE A
1
Oligosaccharide
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2
Unknown
REBAUDIOSIDE A
×
Maximum Phase:
1
First Approval:
None
UNII:
B3FUD0528F
Molecule Type:
Oligosaccharide
Molecular Formula:
C44H70O23
Molecular Weight:
967.02
AlogP:
-5.11
PSA:
374.13
HBD:
14.0
HBA:
#RotB:
12.0
Source:
ONAPRISTONE
1
Small molecule
Investigational
Unknown
Unknown
Breast Neoplasms; Neoplasms; Prostatic Neoplasms
Progesterone receptor antagonist
ONAPRISTONE
×
Maximum Phase:
1
First Approval:
None
UNII:
H6H7G23O3N
Molecule Type:
Small molecule
Molecular Formula:
C29H39NO3
Molecular Weight:
449.64
AlogP:
5.16
PSA:
60.77
HBD:
2.0
HBA:
#RotB:
5.0
Source:
GSK-369796
1
Small molecule
Investigational
Unknown
Unknown
Malaria
Unknown
GSK-369796
×
Maximum Phase:
1
First Approval:
None
UNII:
NSC8QP4B6Z
Molecule Type:
Small molecule
Molecular Formula:
C20H22ClN3O
Molecular Weight:
355.87
AlogP:
5.23
PSA:
57.18
HBD:
3.0
HBA:
#RotB:
4.0
Source:
DELANZOMIB
1
Small molecule
Investigational
Unknown
Unknown
Multiple Myeloma
Unknown
DELANZOMIB
×
Maximum Phase:
1
First Approval:
None
UNII:
6IF28942WO
Molecule Type:
Small molecule
Molecular Formula:
C21H28BN3O5
Molecular Weight:
413.28
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
BEMOTRIZINOL
1
Small molecule
Investigational
Unknown
Unknown
Sunburn
Unknown
BEMOTRIZINOL
×
Maximum Phase:
1
First Approval:
None
UNII:
PWZ1720CBH
Molecule Type:
Small molecule
Molecular Formula:
C38H49N3O5
Molecular Weight:
627.83
AlogP:
9.48
PSA:
106.82
HBD:
2.0
HBA:
#RotB:
18.0
Source:
TIBULIZUMAB
1
Antibody
Investigational
Unknown
Unknown
Arthritis, Rheumatoid; Sjogren's Syndrome
Interleukin 17A inhibitor
TIBULIZUMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
42HQ15W1ZF
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BGT226
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BGT226
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LEVONORGESTREL BUTANOATE
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
LEVONORGESTREL BUTANOATE
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
INCAGN-02385
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
INCAGN-02385
×
Maximum Phase:
1
First Approval:
None
UNII:
Z0A08C63DF
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
E7107
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
E7107
×
Maximum Phase:
1
First Approval:
None
UNII:
R60DZX1E2N
Molecule Type:
Small molecule
Molecular Formula:
C40H66N2O9
Molecular Weight:
718.97
AlogP:
5.05
PSA:
152.53
HBD:
4.0
HBA:
#RotB:
10.0
Source:
1
2
…
80
81
82
83
84
85
86
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA